Table 4.
Variable | EQ-5D | HHS | ||
---|---|---|---|---|
OR | 2.5–97.5% | OR | 2.5–97.5% | |
Surgical approach | ||||
PL approach | 1.00 | Ref | 1.00 | Ref |
DL approach | −0.03 | −0.15 to 0.10, p = 0.65 | −0.40 | −6.3 to 5.7, p = 0.92 |
Cognitive status | ||||
Cognitive impairment | 1.00 | Ref | 1.00 | Ref |
Control group | 0.22 | 0.08–0.35, p = 0.002 | 4.65 | −2.24 to 11.53, p = 0.18 |
Age | −0.02 | −0.02 to 0.001, p = 0.06 | −0.21 | −0.74 to 0.33, p = 0.44 |
Sex | ||||
Male | 1.00 | Ref | 1.00 | Ref |
Female | 0.06 | −0.07 to 0.19, p = 0.43 | 1.02 | −4.9 to 8.5, p = 0.59 |
ASA | ||||
1–2 | 1.00 | Ref | 0.00 | Ref |
3–4 | −0.07 | −0.19 to 0.05, p = 0.26 | 0.07 | −6.2 to 6.4, p = 0.98 |
Preop EQ-5D/HHS | 0.16 | −0.69 to 0.39, p = 0.17 | 0.34 | 0.08 to 0.6, p = 0.01 |
Linear regression including adjusted variables for HHS and EQ-5D
The bold value is significant at p < 0.05